Blood test for multiple cancers in people with symptoms
Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.
This trial tests a new blood test (SPOT-MAS) that looks for signs of multiple cancers in people who already have symptoms and are being checked with imaging. If the blood test is positive, you'll get more detailed scans or a biopsy to see if cancer is present.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have symptoms that might be related to breast, lung, colorectal, stomach, or liver cancer (like a lump, cough, blood in stool, belly pain, or weight loss).
- You have been referred for imaging tests (like ultrasound, X-ray, or endoscopy) to check for cancer.
- You have not had an invasive cancer diagnosis or treatment in the last 5 years.
- You have not had a bone marrow transplant or blood transfusion in the last 3 months.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new blood test that may find early signs of cancer in people who have no symptoms. If you join, you'll have a blood draw, and the study will check if the test can catch cancer early.
This trial uses a blood test to find early signs of cancer or leftover tumor cells after treatment. It may help people with certain cancers or those with non-cancerous growths understand their condition better.
This study is testing a new blood test that may help find multiple types of cancer early. It compares blood samples from people with newly diagnosed cancer to those without cancer.
This trial checks whether a blood test can detect early signs of multiple cancers in people who feel well. It may help find cancer earlier, when treatment is more likely to work.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study is testing a blood-based test to detect unique molecules (called miRNAs) that may signal the presence of several types of gut or digestive system cancers. The goal is to develop a simple screening tool that could catch these cancers earlier.
Hear when a new Cancer Colon trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.